Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion

PR Newswire June 18, 2018

Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops

PR Newswire June 14, 2018

Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins

PR Newswire June 12, 2018

Securities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Valeant Pharmaceuticals International, Inc. During the Period January 4, 2013 Through August 11, 2016, Inclusive

Business Wire June 8, 2018

Detailed Research: Economic Perspectives on Central European Media Enterprises, Valeant Pharmaceuticals International, Nice, NCS Multistage, NewLink Genetics, and Colliers International Group — What Drives Growth in Today's Competitive Landscape

GlobeNewswire June 5, 2018

Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redemption Of Existing Senior Notes

PR Newswire June 1, 2018

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

Benzinga.com  June 1, 2018

Salix To Highlight New Clinical Data During Digestive Disease Week

PR Newswire May 31, 2018

Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching

Benzinga.com  May 19, 2018

Valeant Announces Pricing Of Private Offering Of Notes

PR Newswire May 17, 2018

Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans

PR Newswire May 17, 2018

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  May 15, 2018

Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference

PR Newswire May 15, 2018

VRX Investor Alert: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors

PR Newswire May 15, 2018

Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference

PR Newswire May 10, 2018

Valeant To Seek Refinancing of its Existing Credit Agreement

PR Newswire May 10, 2018

Thinking about buying stock in Advanced Micro Devices, Blink Charging, Disney, Valeant Pharmaceuticals and Walmart Stores?

PR Newswire May 9, 2018

36 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  May 8, 2018

Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health

Benzinga.com  May 8, 2018

Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance

PR Newswire May 8, 2018